Sarah M. Bagley, MD

Associate Professor, Medicine

Sarah Bagley
617.414.7399
801 Massachusetts Ave Crosstown Center

Biography

Sarah Bagley is an Associate Professor of Medicine and Pediatrics at the Chobanian & Avedisian School of Medicine and is board certified in Pediatrics, Internal Medicine, and Addiction Medicine. She is the founder of the CATALYST at Boston Medical Center, a clinical program providing integrated substance use care and primary care for youth where she sees patients. Her passion is to ensure that all youth who use substances have access to high quality, equitable care to promote their health. Her research focus is on the engagement of young adults who use drugs and their families in care to minimize risk for overdose and the complications of drug use. She has funding from the National Institute on Drug Abuse, the Centers for Disease Control and Prevention, and PCORI to conduct research about engagement in treatment and overdose prevention of young adults after nonfatal opioid overdose and reducing stimulant related overdose.

Other Positions

  • Associate Professor, Adolescent Medicine, Pediatrics, Boston University Chobanian & Avedisian School of Medicine
  • Faculty, Clinical Addiction Research and Education Unit, Medicine, Boston University Chobanian & Avedisian School of Medicine

Education

  • Georgetown University School of Medicine, MD
  • Boston University School of Public Health, MSc
  • Brown University, BA

Classes Taught

Publications

  • Published on 7/1/2024

    Calihan JB, Bagley SM. Injectable Buprenorphine: An Opportunity to Improve Treatment Access for Youth With Opioid Use Disorder. J Adolesc Health. 2024 Jul; 75(1):13-14. PMID: 38880557.

    Read at: PubMed
  • Published on 7/1/2024

    Bagley SM, Beetham T, Hadland SE, Wright OR, Korthuis PT, King CA. Adolescent Residential Addiction Treatment: The Authors Reply. Health Aff (Millwood). 2024 Jul; 43(7):1052. PMID: 38950304.

    Read at: PubMed
  • Published on 6/16/2024

    Samet JH, El-Bassel N, Winhusen TJ, Jackson RD, Oga EA, Chandler RK, Villani J, Freisthler B, Adams J, Aldridge A, Angerame A, Babineau DC, Bagley SM, Baker TJ, Balvanz P, Barbosa C, Barocas J, Battaglia TA, Beard DD, Beers D, Blevins D, Bove N, Bridden C, Brown JL, Bush HM, Bush JL, Caldwell R, Calver K, Calvert D, Campbell ANC, Carpenter J, Caspar R, Chassler D, Chaya J, Cheng DM, Cunningham CO, Dasgupta A, David JL, Davis A, Dean T, Drainoni ML, Eggleston B, Fanucchi LC, Feaster DJ, Fernandez S, Figueroa W, Freedman DA, Freeman PR, Freiermuth CE, Friedlander E, Gelberg KH, Gibson EB, Gilbert L, Glasgow L, Goddard-Eckrich DA, Gomori S, Gruss DE, Gulley J, Gutnick D, Hall ME, Harger Dykes N, Hargrove SL, Harlow K, Harris A, Harris D, Helme DW, Holloway J, Hotchkiss J, Huang T, Huerta TR, Hunt T, Hyder A, Ingram VL, Ingram T, Kauffman E, Kimball JL, Kinnard EN, Knott C, Knudsen HK, Konstan MW, Kosakowski S, Larochelle MR, Leaver HM, LeBaron PA, Lefebvre RC, Levin FR, Lewis N, Lewis N, Lofwall MR, Lounsbury DW, Luster JE, Lyons MS, Mack A, Marks KR, Marquesano S, Mauk R, McAlearney AS, McConnell K, McGladrey ML, McMullan J, Miles J, Munoz Lopez R, Nelson A, Neufeld JL, Newman L, Nguyen TQ, Nunes EV, Oller DA, Oser CB, Oyler DR, Pagnano S, Parran TV, Powell J, Powers K, Ralston W, Ramsey K, Rapkin BD, Reynolds JG, Roberts MF, Robertson W, Rock P, Rodgers E, Rodriguez S, Rudorf M, Ryan S, Salsberry P, Salvage M, Sabounchi N, Saucier M, Savitzky C, Schackman B, Schady E, Seiber EE, Shadwick A, Shoben A, Slater MD, Slavova S, Speer D, Sprunger J, Starbird LE, Staton M, Stein MD, Stevens-Watkins DJ, Stopka TJ, Sullivan A, Surratt HL, Sword Cruz R, Talbert JC, Taylor JL, Thompson KL, Vandergrift N, Vickers-Smith RA, Vietze DJ, Walker DM, Walley AY, Walters ST, Weiss R, Westgate PM, Wu E, Young AM, Zarkin GA, Walsh SL. Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths. N Engl J Med. 2024 Jun 16. PMID: 38884347.

    Read at: PubMed
  • Published on 6/1/2024

    Englander H, Thakrar AP, Bagley SM, Rolley T, Dong K, Hyshka E. Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review. JAMA Intern Med. 2024 Jun 01; 184(6):691-701. PMID: 38683591.

    Read at: PubMed
  • Published on 5/31/2024

    Hogue A, Porter NP, Ozechowski TJ, Becker SJ, O'Grady MA, Bobek M, Cerniglia M, Ambrose K, MacLean A, Hadland SE, Cunningham H, Bagley SM, Sherritt L, O'Connell M, Shrier LA, Harris SK. Standard Versus Family-Based Screening, Brief Intervention, and Referral to Treatment for Adolescent Substance Use in Primary Care: Protocol for a Multisite Randomized Effectiveness Trial. JMIR Res Protoc. 2024 May 31; 13:e54486. PMID: 38819923.

    Read at: PubMed
  • Published on 5/1/2024

    Hadland SE, Schmill DM, Bagley SM. Anticipatory Guidance to Prevent Adolescent Overdoses. Pediatrics. 2024 May 01; 153(5). PMID: 38563066.

    Read at: PubMed
  • Published on 3/19/2024

    Schoenberger SF, Cummins ER, Carroll JJ, Yan S, Lambert A, Bagley SM, Xuan Z, Green TC, Cook F, Yule AM, Walley AY, Formica SW. "Wanna cry this out real quick?": an examination of secondary traumatic stress risk and resilience among post-overdose outreach staff in Massachusetts. Harm Reduct J. 2024 Mar 19; 21(1):66. PMID: 38504244.

    Read at: PubMed
  • Published on 1/25/2024

    Bagley S, Glover D, Foreman J, Hadland S, Punch LJ, Taichman D. Effective Treatments for Opioid Use Disorder - Finding Recovery and Staying Safe. N Engl J Med. 2024 Jan 25; 390(4):e7. PMID: 38265643.

    Read at: PubMed
  • Published on 1/11/2024

    Bagley S, Barnes J, Blunt B, Foreman J, Hadland S, Mayen S, McMahan R, Punch LJ, Taichman D. Treating Opioid Use Disorder in General Practice - Diagnosis, Harm Reduction, and Medications. N Engl J Med. 2024 Jan 11; 390(2):e3. PMID: 38197814.

    Read at: PubMed
  • Published on 1/4/2024

    Beaugard CA, Formica SW, Cummins ER, Bagley SM, Beletsky L, Green TC, Murray SP, Yan S, Xuan Z, Walley AY, Carroll JJ. Privacy and confidentiality in Massachusetts' post-overdose outreach programs: Mixed methods analysis of outreach staff surveys and interviews. Int J Drug Policy. 2024 Feb; 124:104310. PMID: 38181671.

    Read at: PubMed

View 69 more publications: View full profile at BUMC

View all profiles